Venture Kick

Unomr develops novel nano-​micro technology based sensing approaches for diagnostics and drug discovery.

MinWave provides 10 times smaller and lighter microwave devices through patented technology for subwavelength engineering.

MinWave provides 10 times smaller and lighter microwave devices through patented technology for subwavelength engineering.

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.

Infrascreen uses nano-technologies to design the next generation of greenhouse screens. Infrascreen develops light filters using nanotechnologies that enable drastic improvements in climate management within greenhouses. Our filters aim at better energy efficiency and reduced heat stress for the crops. We are co-developing with the PV-center of the CSEM in Neuchâtel. As of today, we have demonstrated the proof of concept of our product in lab conditions.

XRnanotech GmbH is a Swiss company specializing in the development and manufacture of advanced nanotech X-ray optics tailored for high-energy applications. Founded in 2020 and located in Untersiggenthal, the company produces high aspect ratio Fresnel zone plates, beam-shaping condensers for X-ray microscopy, as well as 2D and 3D resolution test targets, gratings, and beam splitters. These innovative optical solutions enable precise focusing of high-energy beams on small samples, facilitating applications in drug discovery, medical imaging, microchip inspection, and the study of advanced materials. XRnanotech's products are designed to meet the needs of high-tech industries requiring detailed analysis of nanoscale systems.

Eldico Scientific AG, founded in 2019 and based in Villigen, Switzerland, specializes in the development and manufacturing of electron diffractometers designed for the analysis of solid compounds. The company's innovative instruments enable researchers in various fields, including pharmaceuticals, agrochemicals, and advanced materials, to characterize nano-crystalline systems that were previously difficult to measure. By providing tools for nano-crystallographic investigations, Eldico aims to enhance the efficiency and cost-effectiveness of structural information gathering, thereby accelerating the drug discovery and development process. The company has made significant strides in the field, achieving proof of concept for its technology in collaboration with leading Swiss research institutions, and has received recognition for its contributions to scientific advancement.

Swistor specializes in the development of high energy and ultra fast-charging battery replacements, utilizing carbon nanotube supercapacitors to enhance charging speed and extend battery life. The company aims to provide solutions that allow electronic devices to charge in under two minutes while ensuring the use of environmentally friendly and safe materials. Targeting major mobile phone manufacturers and the growing sector of self-powered IoT devices, Swistor seeks to enable businesses to offer superior battery performance in their products, promoting sustainability and efficiency in energy storage solutions.

Nutrix is a Swiss health-tech company founded in 2019 and based in Basel. It specializes in developing a nanosensor that is placed on the tooth to measure glucose levels in saliva, providing a non-invasive method for users to monitor their health. This technology is integrated with an external application that tracks food intake and offers dietary advice, aiming to aid in the prevention of diabetes. Nutrix combines artificial intelligence with wearables to create cost-effective healthcare solutions. In 2025, the company plans to introduce CortiSense, a non-invasive cortisol monitoring sensor that has already received a CES Innovation Award, further expanding its portfolio of health monitoring technologies. Through its innovative approach, Nutrix enables users to manage their health conditions effectively without the need for frequent medical consultations.

XRnanotech GmbH is a Swiss company specializing in the development and manufacture of advanced nanotech X-ray optics tailored for high-energy applications. Founded in 2020 and located in Untersiggenthal, the company produces high aspect ratio Fresnel zone plates, beam-shaping condensers for X-ray microscopy, as well as 2D and 3D resolution test targets, gratings, and beam splitters. These innovative optical solutions enable precise focusing of high-energy beams on small samples, facilitating applications in drug discovery, medical imaging, microchip inspection, and the study of advanced materials. XRnanotech's products are designed to meet the needs of high-tech industries requiring detailed analysis of nanoscale systems.

Anavo Medical specializes in developing nanoparticle-based pharmaceutical products aimed at enhancing wound healing and minimizing complications associated with skin grafts. The company's innovative formulation utilizes bioactive nanoparticles suspended in a user-friendly matrix, incorporating active ingredients such as metal oxide nanoparticles. These components possess anti-inflammatory and neo-angiogenic properties, which stimulate blood vessel regeneration and mitigate inflammation. By leveraging advanced nanotechnology, Anavo Medical's products empower healthcare professionals to improve patient outcomes, ensuring safer surgeries and promoting faster recovery for individuals undergoing skin transplantation procedures.

Eldico Scientific AG, founded in 2019 and based in Villigen, Switzerland, specializes in the development and manufacturing of electron diffractometers designed for the analysis of solid compounds. The company's innovative instruments enable researchers in various fields, including pharmaceuticals, agrochemicals, and advanced materials, to characterize nano-crystalline systems that were previously difficult to measure. By providing tools for nano-crystallographic investigations, Eldico aims to enhance the efficiency and cost-effectiveness of structural information gathering, thereby accelerating the drug discovery and development process. The company has made significant strides in the field, achieving proof of concept for its technology in collaboration with leading Swiss research institutions, and has received recognition for its contributions to scientific advancement.

Anavo Medical specializes in developing nanoparticle-based pharmaceutical products aimed at enhancing wound healing and minimizing complications associated with skin grafts. The company's innovative formulation utilizes bioactive nanoparticles suspended in a user-friendly matrix, incorporating active ingredients such as metal oxide nanoparticles. These components possess anti-inflammatory and neo-angiogenic properties, which stimulate blood vessel regeneration and mitigate inflammation. By leveraging advanced nanotechnology, Anavo Medical's products empower healthcare professionals to improve patient outcomes, ensuring safer surgeries and promoting faster recovery for individuals undergoing skin transplantation procedures.

Nanotech SWHL develops technology for the lithography stage of IC production – Sub-Wavelength Holographic Lithography (SWHL). Lithography is the main tool in IC patterning on silicon wafers. Photolithography, i. e. lithography, based on light imaging, has been driving the semiconductor industry for decades. However, the most commonly used lithography technology — projection photolithography with a deep ultraviolet light source (known as "DUVL" or "193 nm ArF") has exhausted its potential to further decrease resolution at reasonable costs. SWHL overcomes this deadlock in the photolithography development. SWHL, with very simple lithography tool (holographic stepper), and holographic masks that are considerably easier to produce and service (due inter alia to their low sensitivity to defects), has all the potential to become DUVL successful alternative. SWHL is not the interferential lithography, that first pops up when googling "holographic lithography". Interferential lithography is able to create only periodic images while SWHL is able to produce any image you need.

ALAnostics is a biopharmaceutical company that specializes in oncodiagnostics, originating as a spin-off from the University of Geneva. The company focuses on developing innovative tumour painting technology designed to assist surgeons in the real-time identification and removal of breast cancer during surgery. By utilizing nanomedicines for fluorescence-guided surgery, along with 5-ALA prodrugs for photodynamic therapy and light-activated antimicrobials, ALAnostics aims to enhance the accuracy of tumor removal, ultimately improving patient outcomes and saving lives.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

Daphne Technology SA is a climate technology company based in Ecublens, Switzerland, founded in 2017. The company specializes in developing a catalyst-free, nano-technology aimed at reducing air emissions for industries such as petrochemical, power, and transportation. Its patented solutions are designed to be miniaturized, making them particularly suitable for marine vessels. By effectively breaking down toxic pollutants into non-hazardous elements, the technology not only meets international and national regulatory requirements but also offers significant cost advantages. It allows for a substantial reduction in operating costs without necessitating a change in fuel type, thereby enabling cleaner emissions for ships using current and future fuels, including ammonia and hydrogen.

Resistell AG, founded in 2018 and located in Muttenz, Switzerland, develops and markets a diagnostic device for antibiotic susceptibility testing. Utilizing nanomotion technology, the device detects the movement of living bacterial cells to assess their resistance to antibiotics, offering a rapid alternative to traditional culture-based methods. This innovative approach allows for timely and accurate identification of the most effective antibiotics for patients, addressing the growing challenge of antibiotic resistance.

Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

Qnami AG is a Swiss company established in 2017, specializing in the development of quantum sensing technologies for nanoscale imaging. The company manufactures non-invasive sensors, including the ProteusQ magnetic imaging microscope and the Quantum Diamond product line, which features diamond probes with single nitrogen-vacancy (NV) centers for high-resolution magnetic imaging. These advanced technologies enable the measurement of electric and magnetic fields with exceptional sensitivity, facilitating a range of applications such as the characterization of magnetic random-access memory (MRAM), imaging of proteins, and fundamental studies of superconductors. Qnami's innovations unlock new possibilities in both scientific research and industrial applications, aiming to enhance understanding and improve various aspects of life and technology.

IbtiCare specializes in advanced antibacterial technology that utilizes Physical Vapor Deposition (PVD) to create coatings with nanoparticles that render surfaces antibacterial. This innovative solution effectively targets and eliminates a broad spectrum of dangerous bacteria, including those resistant to conventional drugs. The technology is designed to be fast-reactive, durable, and stable, ensuring long-lasting protection for various surfaces. IbtiCare's antibacterial solution has successfully passed clinical trials and has received validation from leaders in the healthcare sector, positioning it as a superior alternative to traditional antibacterial methods. The company's mission is to combat bacterial infections and enhance safety across multiple environments.

Nanogence SA, established in 2017 and located in Renens, Switzerland, specializes in the development of innovative material solutions for the construction industry. The company focuses on creating synthetic, tailor-made materials that enhance the performance and sustainability of construction applications, including cement and concrete. By leveraging advanced knowledge in chemistry, material science, and nanotechnology, Nanogence has developed patented additive formulations that significantly improve the binding efficiency of cement and concrete while reducing carbon emissions by up to 50%. This enables manufacturers to achieve valuable cost savings, enhance durability, and contribute to more sustainable construction practices in a rapidly growing global market.

Daphne Technology SA is a climate technology company based in Ecublens, Switzerland, founded in 2017. The company specializes in developing a catalyst-free, nano-technology aimed at reducing air emissions for industries such as petrochemical, power, and transportation. Its patented solutions are designed to be miniaturized, making them particularly suitable for marine vessels. By effectively breaking down toxic pollutants into non-hazardous elements, the technology not only meets international and national regulatory requirements but also offers significant cost advantages. It allows for a substantial reduction in operating costs without necessitating a change in fuel type, thereby enabling cleaner emissions for ships using current and future fuels, including ammonia and hydrogen.

IbtiCare specializes in advanced antibacterial technology that utilizes Physical Vapor Deposition (PVD) to create coatings with nanoparticles that render surfaces antibacterial. This innovative solution effectively targets and eliminates a broad spectrum of dangerous bacteria, including those resistant to conventional drugs. The technology is designed to be fast-reactive, durable, and stable, ensuring long-lasting protection for various surfaces. IbtiCare's antibacterial solution has successfully passed clinical trials and has received validation from leaders in the healthcare sector, positioning it as a superior alternative to traditional antibacterial methods. The company's mission is to combat bacterial infections and enhance safety across multiple environments.

NanoLockin GmbH, founded in 2018 and based in Fribourg, Switzerland, specializes in developing advanced algorithm and software solutions for nanoparticle analysis using ultrasensitive infrared imaging. The company has created a detection and analysis platform that sets a new benchmark for identifying and evaluating nanoparticles across a variety of products. This platform allows manufacturers and research laboratories to assess different types of nanoparticles, facilitating the measurement of a wide range of samples. By providing analytical instruments tailored for those involved in nanoparticle research and development, NanoLockin supports the growing need for precise nanoparticle detection in diverse applications.

Eldico Scientific AG, founded in 2019 and based in Villigen, Switzerland, specializes in the development and manufacturing of electron diffractometers designed for the analysis of solid compounds. The company's innovative instruments enable researchers in various fields, including pharmaceuticals, agrochemicals, and advanced materials, to characterize nano-crystalline systems that were previously difficult to measure. By providing tools for nano-crystallographic investigations, Eldico aims to enhance the efficiency and cost-effectiveness of structural information gathering, thereby accelerating the drug discovery and development process. The company has made significant strides in the field, achieving proof of concept for its technology in collaboration with leading Swiss research institutions, and has received recognition for its contributions to scientific advancement.

Morphotonix Sàrl, founded in 2014 and based in Lausanne, Switzerland, specializes in anti-counterfeiting solutions through innovative nano-imprinting technology. The company develops films and labels that incorporate holographic-like effects directly onto complex geometric products without the use of additives. This method involves micro or nano-patterning on master molds for the industrial production of polymeric items, creating controlled roughness at the micrometer scale. Morphotonix's approach allows for the embedding of unique security features within products, which aids in preventing counterfeiting while maintaining material purity. This technology not only eliminates the need for additional labels or printing but also provides brands with a cost-effective means of authenticating their products instantly.

Morphotonix Sàrl, founded in 2014 and based in Lausanne, Switzerland, specializes in anti-counterfeiting solutions through innovative nano-imprinting technology. The company develops films and labels that incorporate holographic-like effects directly onto complex geometric products without the use of additives. This method involves micro or nano-patterning on master molds for the industrial production of polymeric items, creating controlled roughness at the micrometer scale. Morphotonix's approach allows for the embedding of unique security features within products, which aids in preventing counterfeiting while maintaining material purity. This technology not only eliminates the need for additional labels or printing but also provides brands with a cost-effective means of authenticating their products instantly.

Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board).

Scrona specializes in micro- and nanotechnology, focusing on innovative solutions for both consumer and industrial applications. The company has developed a three-dimensional nano drip printing technology aimed at facilitating fast and cost-effective production processes. Scrona's core competency lies in printhead development, collaborating with partners to offer comprehensive manufacturing equipment and next-generation products. This enables businesses to produce high-quality printed materials efficiently and at reduced costs, contributing to advancements in micro- and nanofabrication.

Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board).

SwissLitho is a high-tech company focused on revolutionizing the fabrication of nanostructures through its innovative nanolithography tool, the NanoFrazor. Originating from the Millipede project at IBM Research Zurich, this patented technology employs heatable silicon tips for both patterning and imaging high-resolution nanostructures. SwissLitho's solutions enhance the capabilities of nanofabrication, facilitating advancements across various scientific and technological domains. Founded in 2012, the company has garnered numerous prestigious awards for its contributions to technology and innovation. With a diverse team of engineers and scientists from over ten countries, SwissLitho serves a global customer base, positioning itself as a key player in the field of nanotechnology.

Naneos specializes in the production of advanced nanoparticle detection instruments, manufactured in Switzerland. The company focuses on creating high-quality devices that are smaller and more user-friendly than those offered by competitors. Their innovative technology employs non-contact detection methods using induced currents to accurately measure the lung-deposited surface area of nanoparticles. This capability allows consumers to effectively monitor air quality. With features such as self-testing, Naneos aims to enhance the functionality and reliability of their products while maintaining competitive pricing.

Scrona specializes in micro- and nanotechnology, focusing on innovative solutions for both consumer and industrial applications. The company has developed a three-dimensional nano drip printing technology aimed at facilitating fast and cost-effective production processes. Scrona's core competency lies in printhead development, collaborating with partners to offer comprehensive manufacturing equipment and next-generation products. This enables businesses to produce high-quality printed materials efficiently and at reduced costs, contributing to advancements in micro- and nanofabrication.

SwissLitho is a high-tech company focused on revolutionizing the fabrication of nanostructures through its innovative nanolithography tool, the NanoFrazor. Originating from the Millipede project at IBM Research Zurich, this patented technology employs heatable silicon tips for both patterning and imaging high-resolution nanostructures. SwissLitho's solutions enhance the capabilities of nanofabrication, facilitating advancements across various scientific and technological domains. Founded in 2012, the company has garnered numerous prestigious awards for its contributions to technology and innovation. With a diverse team of engineers and scientists from over ten countries, SwissLitho serves a global customer base, positioning itself as a key player in the field of nanotechnology.

SwissLitho is a high-tech company focused on revolutionizing the fabrication of nanostructures through its innovative nanolithography tool, the NanoFrazor. Originating from the Millipede project at IBM Research Zurich, this patented technology employs heatable silicon tips for both patterning and imaging high-resolution nanostructures. SwissLitho's solutions enhance the capabilities of nanofabrication, facilitating advancements across various scientific and technological domains. Founded in 2012, the company has garnered numerous prestigious awards for its contributions to technology and innovation. With a diverse team of engineers and scientists from over ten countries, SwissLitho serves a global customer base, positioning itself as a key player in the field of nanotechnology.

Abionic SA is a Swiss company specializing in nanotechnology-based diagnostic solutions aimed at enhancing medical diagnosis. Founded in 2010 as a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), Abionic has developed the abioSCOPE platform, which enables rapid testing of patients' allergy profiles using just a single drop of blood. This innovative platform includes a reader for nanofluidic sensors and a smartphone application, facilitating both clinical laboratory use and point-of-care testing. Abionic's products are designed to assist healthcare professionals in diagnosing and screening various medical conditions, particularly in the realms of allergy and sepsis. The company is ISO 9001/13485 certified, demonstrating its commitment to quality management in the development and commercialization of in vitro diagnostic devices. With strategic support from various Swiss institutions, Abionic aims to become a significant player in personalized medicine on an international scale. The company is headquartered in Lausanne, Switzerland.

Abionic SA is a Swiss company specializing in nanotechnology-based diagnostic solutions aimed at enhancing medical diagnosis. Founded in 2010 as a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), Abionic has developed the abioSCOPE platform, which enables rapid testing of patients' allergy profiles using just a single drop of blood. This innovative platform includes a reader for nanofluidic sensors and a smartphone application, facilitating both clinical laboratory use and point-of-care testing. Abionic's products are designed to assist healthcare professionals in diagnosing and screening various medical conditions, particularly in the realms of allergy and sepsis. The company is ISO 9001/13485 certified, demonstrating its commitment to quality management in the development and commercialization of in vitro diagnostic devices. With strategic support from various Swiss institutions, Abionic aims to become a significant player in personalized medicine on an international scale. The company is headquartered in Lausanne, Switzerland.

Imina Technologies is a Swiss manufacturer specializing in robotic solutions for the characterization of samples under optical and scanning electron microscopes. The company develops precision robotic technology that enables the semiconductor industry to enhance product safety by providing high-precision services for sample interaction and characterization at the nanometer scale. Utilizing a unique motion technology, Imina's systems position probes with exceptional accuracy while maintaining stable electrical contacts. This innovative approach allows clients to achieve deep integration with various microscopy and semiconductor test equipment, solidifying Imina Technologies' reputation as a leader in the semiconductor test equipment market, particularly in nanoprobing and electrical failure analysis.

Nanotion AG, founded in June 2010 in Zurich, Switzerland, specializes in manufacturing analytical devices designed for the water, food, pharmaceutical, and chemical industries. The company focuses on detecting and characterizing nanoparticles in liquid media, offering both technology as a service and analytical devices to address the challenges associated with nanosized particle analysis. Founded by Dr. Christopher Latkoczy and Bartjan den Hartogh, Nanotion emerged from a technical collaboration with ETH Zurich and Eawag. The company's mission is to optimize industrial processes and mitigate risks linked to the use of nanomaterials, ensuring safer applications across various sectors. Tom Forrer, who has been with Nanotion since its inception, plays a key role in algorithm programming and software development, supporting the company's commitment to providing effective solutions for nanoparticle analysis.

Imina Technologies is a Swiss manufacturer specializing in robotic solutions for the characterization of samples under optical and scanning electron microscopes. The company develops precision robotic technology that enables the semiconductor industry to enhance product safety by providing high-precision services for sample interaction and characterization at the nanometer scale. Utilizing a unique motion technology, Imina's systems position probes with exceptional accuracy while maintaining stable electrical contacts. This innovative approach allows clients to achieve deep integration with various microscopy and semiconductor test equipment, solidifying Imina Technologies' reputation as a leader in the semiconductor test equipment market, particularly in nanoprobing and electrical failure analysis.

Ninart Sàrl allows manipulation and multi-dimensional characterization of soft samples at the nanoscale. It develops and commercializes new scientific instrumentation in nanotechnologies using optical tweezers.

Imina Technologies is a Swiss manufacturer specializing in robotic solutions for the characterization of samples under optical and scanning electron microscopes. The company develops precision robotic technology that enables the semiconductor industry to enhance product safety by providing high-precision services for sample interaction and characterization at the nanometer scale. Utilizing a unique motion technology, Imina's systems position probes with exceptional accuracy while maintaining stable electrical contacts. This innovative approach allows clients to achieve deep integration with various microscopy and semiconductor test equipment, solidifying Imina Technologies' reputation as a leader in the semiconductor test equipment market, particularly in nanoprobing and electrical failure analysis.

ExCellness provides non-degradable tissue culture surfaces with the elasticity of human tissue, ranging from the stiffness of bone to the softness of brain. Culturing your cells on their adapted culture substrates makes them "FEELING AT HOME"! ExCellness Biotech was incorporated in 2009 as a spin-off project from the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland. ExCellness maintains close contact with the EPFL research competencies but is also actively collaborating with the University of Toronto (UoT), Ontario, Canada to further develop eslatic substrates to culture cells in biomimetic conditions.

ExCellness provides non-degradable tissue culture surfaces with the elasticity of human tissue, ranging from the stiffness of bone to the softness of brain. Culturing your cells on their adapted culture substrates makes them "FEELING AT HOME"! ExCellness Biotech was incorporated in 2009 as a spin-off project from the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland. ExCellness maintains close contact with the EPFL research competencies but is also actively collaborating with the University of Toronto (UoT), Ontario, Canada to further develop eslatic substrates to culture cells in biomimetic conditions.

Attolight specializes in the development of advanced cathodoluminescence instruments that combine electron and light microscopy technologies. These innovative tools enable time-resolved measurements of carrier dynamics in nanostructures, significantly enhancing the efficiency of materials such as semiconductors, phosphors, ceramics, rocks, and glass. By integrating cathodoluminescence with hyperspectral imaging, Attolight's solutions provide unparalleled insights into ultra-trace impurities and crystallographic defects that are often undetectable with conventional imaging methods. This streamlined approach transforms what was once a complex and cumbersome experimental process into an efficient practice, allowing researchers to conduct studies with nanometer resolution and pico-second timing. Through its cutting-edge technology, Attolight is poised to impact various fields significantly, including the improvement of LED, laser diode, and solar cell performance.

Aleva Neurotherapeutics develops the next generations of implantable Deep Brain Stimulation systems, based on a MEMS technology. Our unique microfabricated devices enable Target Specific Stimulation and optimization of current therapies. They will also permit targeting new areas of the brain and the measurement of neurophysiological activity, translating into faster, more certain surgical placement of electrode leads. The first application will be in Deep Brain Stimulation for indications such as Parkinson's Disease and Essential Tremor. To maximize the value it can capture from its technology, Aleva intends to develop a series of two therapeutic products, while eliminating technological and clinical development risks at each stage. Our first product, directSTIM, an intelligent directional electrode connected to a best-in-class Deep Brain Stimulation system, has successfully completed an acute clinical trial at the Inselspital in Bern, Switzerland. It is currently further developped for a long term use. Aleva has been was founded in 2008 in Lausanne, Switzerland. It has raised 42 MUSD to date from prominent VCs, private investors and a strategic investor. The company is ISO13485 certified.

Attolight specializes in the development of advanced cathodoluminescence instruments that combine electron and light microscopy technologies. These innovative tools enable time-resolved measurements of carrier dynamics in nanostructures, significantly enhancing the efficiency of materials such as semiconductors, phosphors, ceramics, rocks, and glass. By integrating cathodoluminescence with hyperspectral imaging, Attolight's solutions provide unparalleled insights into ultra-trace impurities and crystallographic defects that are often undetectable with conventional imaging methods. This streamlined approach transforms what was once a complex and cumbersome experimental process into an efficient practice, allowing researchers to conduct studies with nanometer resolution and pico-second timing. Through its cutting-edge technology, Attolight is poised to impact various fields significantly, including the improvement of LED, laser diode, and solar cell performance.